| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.23 | 0.0002 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.23 | 0.0004 |